Upcoming multi-visceral robotic surgery systems: a SAGES review
2024

Review of Upcoming Robotic Surgery Systems

publication Evidence: moderate

Author Information

Author(s): Sarin Ankit, Samreen Sarah, Moffett Jennifer M., Inga-Zapata Edmundo, Bianco Francesco, Alkhamesi Nawar A., Owen Jacob D., Shahi Niti, DeLong Jonathan C., Stefanidis Dimitrios, Schlachta Christopher M., Sylla Patricia, Azagury Dan E.

Primary Institution: University of CA – Davis Health

Hypothesis

What are the emerging robotic surgical platforms expected to reach US consumers in the next few years?

Conclusion

The emergence of novel robotic surgical platforms represents an important evolution in the growth of minimally invasive surgery.

Supporting Evidence

  • Twenty robotic platforms were identified that met the selection criteria.
  • Ten companies were based in North America, and ten were based in Europe or Asia.
  • Each system is described in detail and key features are summarized for easy comparison.

Takeaway

This study looks at new robotic surgery systems that will soon be available, which could make surgeries easier and cheaper for patients.

Methodology

The SAGES Robotic Platforms Working Group identified robotic surgery platforms in various stages of development and selected multi-visceral systems nearing or completing the FDA approval process.

Limitations

The specific clinical applications and long-term roles of the platforms remain to be fully understood.

Digital Object Identifier (DOI)

10.1007/s00464-024-11384-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication